Mouse resistin modulates adipogenesis and glucose uptake in 3T3-L1 preadipocytes through the ROR1 receptor

Molecular Endocrinology

Volumn 26, Issue 1, 2012, Pages 110-127

  Sánchez Solana, Beatriz ^a   Laborda, Jorge ^a   Baladrón, Victoriano ^a  

^a University of Castilla La Mancha   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DECORIN; GLUCOSE; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 4; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; RECEPTOR TYROSINE KINASE LIKE ORPHAN RECEPTOR; RECEPTOR TYROSINE KINASE LIKE ORPHAN RECEPTOR 1; RESISTIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; UNCLASSIFIED DRUG;

ADIPOGENESIS; ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GLUCOSE HOMEOSTASIS; GLUCOSE TRANSPORT; INSULIN RESISTANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ANIMALS; CELL LINE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION; GLUCOSE; GLUCOSE TRANSPORTER TYPE 1; GLUCOSE TRANSPORTER TYPE 4; HEK293 CELLS; HUMANS; INSULIN RESISTANCE; MICE; NIH 3T3 CELLS; PHOSPHORYLATION; RECEPTOR TYROSINE KINASE-LIKE ORPHAN RECEPTORS; RESISTIN; SIGNAL TRANSDUCTION; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS;

EID: 84855210399     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2011-1027     Document Type: Article

References (57)

1. Galic S, Oakhill JS, Steinberg GR 2010 Adipose tissue as an endocrine organ. Mol Cell Endocrinol 316:129-139
2. Steppan CM, Lazar MA 2002 Resistin and obesity-associated insulin resistance. Trends Endocrinol Metab 13:18-23
3. Steppan CM, Lazar MA 2004 The current biology of resistin. J Intern Med 255:439-447
4. Filková M, Haluzík M, Gay S, Senolt L 2009 The role of resistin as a regulator of inflammation: implications for various human pathologies. Clin Immunol 133:157-170
5. Steppan CM, Brown EJ, Wright CM, Bhat S, Banerjee RR, Dai CY, Enders GH, Silberg DG, Wen X, Wu GD, Lazar MA 2001 A family of tissue-specific resistin-like molecules. Proc Natl Acad Sci USA 98:502-506
6. Kim KH, Lee K, Moon YS, Sul HS 2001 A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J Biol Chem 276:11252-11256
7. Holcomb IN, Kabakoff RC, Chan B, Baker TW, Gurney A, Henzel W, Nelson C, Lowman HB, Wright BD, Skelton NJ, Frantz GD, Tumas DB, Peale Jr FV, Shelton DL, Hébert CC 2000 FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J 19:4046-4055
8. Patel SD, Rajala MW, Rossetti L, Scherer PE, Shapiro L 2004 Disulfide-dependent multimeric assembly of resistin family hormones. Science 304:1154-1158
9. Ghosh S, Singh AK, Aruna B, Mukhopadhyay S, Ehtesham NZ 2003 The genomic organization of mouse resistin reveals major differences from the human resistin: functional implications. Gene 305:27-34
10. Del Arco A, Peralta S, Carrascosa JM, Ros M, Andrés A, Arribas C 2003 Alternative splicing generates a novel non-secretable resistin isoform in Wistar rats. FEBS Lett 555:243-249
11. Schwartz DR, Lazar MA 2011 Human resistin: found in translation from mouse to man. Trends Endocrinol Metab 22:259-265
12. Kim KH, Zhao L, Moon Y, Kang C, Sul HS 2004 Dominant inhibitory adipocyte-specific secretory factor (ADSF)/resistin enhances adipogenesis and improves insulin sensitivity. Proc Natl Acad Sci USA 101:6780-6785
13. Barnes KM, Miner JL 2009 Role of resistin in insulin sensitivity in rodents and humans. Curr Protein Pept Sci 10:96-107
14. Steppan CM, Wang J, Whiteman EL, Birnbaum MJ, Lazar MA 2005 Activation of SOCS-3 by resistin. Mol Cell Biol 25:1569-1575
15. Tarkowski A, Bjersing J, Shestakov A, Bokarewa MI 2009 Resistin competes with lipopolysaccharide for binding to Toll-like receptor 4. J Cell Mol Med
16. Jiang C, Zhang H, Zhang W, Kong W, Zhu Y, Zhang H, Xu Q, Li Y, Wang X 2009 Homocysteine promotes vascular smooth muscle cell migration by induction of the adipokine resistin. Am J Physiol Cell Physiol 297:C1466-C1476
17. Robertson SA, Rae CJ, Graham A 2009 Induction of angiogenesis by murine resistin: putative role of PI3-kinase and NO-dependent pathways. Regul Pept 152:41-47
18. Thommesen L, Stunes AK, Monjo M, Grøsvik K, Tamburstuen MV, Kjøbli E, Lyngstadaas SP, Reseland JE, Syversen U 2006 Expression and regulation of resistin in osteoblasts and osteoclasts indicate a role in bone metabolism. J Cell Biochem 99:824-834
19. Liu F, Guo XR, Gong HX, Ni YH, Fei L, Pan XQ, Guo M, ChenRH 2006 A resistin binding peptide selected by phage display inhibits 3T3-L1 preadipocyte differentiation. Chin Med J 119:496-503
20. Daquinag AC, Zhang Y, Amaya-Manzanares F, Simmons PJ, Kolonin MG 2011 An isoform of decorin is a resistin receptor on the surface of adipose progenitor cells. Cell Stem Cell 9:74-86
21. Gong H, Ni Y, Guo X, Fei L, Pan X, Guo M, Chen R 2004 Resistin promotes 3T3-L1 preadipocyte differentiation. Eur J Endocrinol 150:885-892
22. Guo XR, Gong HX, Gao YQ, Fei L, Ni YH, Chen RH 2004 A mutation in signal peptide of rat resistin gene inhibits differentiation of 3T3-L1 preadipocytes. Acta Pharmacol Sin 25:1705-1711
23. Gu N, Han SP, Fei L, Pan XQ, Guo M, Chen RH, Guo XR 2007 Resistin-binding peptide antagonizes role of resistin on white adipose tissue. Acta Pharmacol Sin 28:221-226
24. Banerjee RR, Rangwala SM, Shapiro JS, Rich AS, Rhoades B, Qi Y, Wang J, Rajala MW, Pocai A, Scherer PE, Steppan CM, Ahima RS, Obici S, Rossetti L, Lazar MA 2004 Regulation of fasted blood glucose by resistin. Science 303:1195-1198
25. Katoh M 2005 Comparative genomics on ROR1 and ROR2 orthologs. Oncol Rep 14:1381-1384
26. Masiakowski P, Carroll RD 1992 A novel family of cell surface receptors with tyrosine kinase-like domain. J Biol Chem 267: 26181-26190
27. Cadigan KM, Nusse R 1997 Wnt signaling: a common theme in animal development. Genes Dev 11:3286-3305
28. Oishi I, Takeuchi S, Hashimoto R, Nagabukuro A, Ueda T, Liu ZJ, Hatta T, Akira S, Matsuda Y, Yamamura H, Otani H, Minami Y 1999 Spatio-temporally regulated expression of receptor tyrosine kinases, mRor1, mRor2, during mouse development: implications in development and function of the nervous system. Genes Cells 4:41-56
29. Liu Y, Bhat RA, Seestaller-Wehr LM, Fukayama S, Mangine A, Moran RA, Komm BS, Bodine PV, Billiard J 2007 The orphan receptor tyrosine kinase Ror2 promotes osteoblast differentiation and enhances ex vivo bone formation. Mol Endocrinol 21:376-387
30. Lyashenko N, Weissenböck M, Sharir A, Erben RG, Minami Y, Hartmann C 2010 Mice lacking the orphan receptor ror1 have distinct skeletal abnormalities and are growth retarded. Dev Dyn 239:2266-2277
31. Fukuda T, Chen L, Endo T, Tang L, Lu D, Castro JE, Widhopf 2nd GF, Rassenti LZ, Cantwell MJ, Prussak CE, Carson DA, Kipps TJ 2008 Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal antigen and receptor for Wnt5a. Proc Natl Acad Sci USA 105:3047-3052
32. Blumenthal A, Ehlers S, Lauber J, Buer J, Lange C, Goldmann T, Heine H, Brandt E, Reiling N 2006 The Wingless homolog WNT5A and its receptor Frizzled-5 regulate inflammatory responses of human mononuclear cells induced by microbial stimulation. Blood 108:965-973
33. Mikels A, Minami Y, Nusse R 2009 Ror2 receptor requires tyrosine kinase activity to mediate Wnt5A signaling. J Biol Chem 284: 30167-30176
34. Liu Y, Ross JF, Bodine PV, Billiard J 2007 Homodimerization of Ror2 tyrosine kinase receptor induces 14-3-3(β) phosphorylation and promotes osteoblast differentiation and bone formation. Mol Endocrinol 21:3050-3061
35. Liu Y, Rubin B, Bodine PV, Billiard J 2008 Wnt5a induces homodimerization and activation of Ror2 receptor tyrosine kinase. J Cell Biochem 105:497-502
36. Yang Y, Xiao M, Mao Y, Li H, Zhao S, Gu Y, Wang R, Yu J, Zhang X, Irwin DM, Niu G, Tan H 2009 Resistin and insulin resistance in hepatocytes: resistin disturbs glycogen metabolism at the protein level. Biomed Pharmacother 63:366-374
37. Steinberg GR, Watt MJ, Febbraio MA 2009 Cytokine Regulation of AMPK signalling. Front Biosci 14:1902-1916
38. Prusty D, Park BH, Davis KE, Farmer SR 2002 Activation of MEK/ ERK signaling promotes adipogenesis by enhancing peroxisome proliferator-activated receptor γ (PPAR_) and C/EBPγ gene expression during the differentiation of 3T3-L1 preadipocytes. J Biol Chem 277:46226-46232
39. Bost F, Aouadi M, Caron L, Even P, Belmonte N, Prot M, Dani C, Hofman P, Pagès G, Pouysségur J, Le Marchand-Brustel Y, Binétruy B 2005 The extracellular signal-regulated kinase isoform ERK1 is specifically required for in vitro and in vivo adipogenesis. Diabetes 54:402-411
40. Fu Y, Luo L, Luo N, Garvey WT 2006 Proinflammatory cytokine production and insulin sensitivity regulated by overexpression of resistin in 3T3-L1 adipocytes. Nutr Metab 3:28
41. Seidler DG, Dreier R 2008 Decorin and its galactosaminoglycan chain: extracellular regulator of cellular function? IUBMB Life 60: 729-733
42. Mochida Y, Parisuthiman D, Pornprasertsuk-Damrongsri S, Atsawasuwan P, Sricholpech M, Boskey AL, Yamauchi M 2009 Decorin modulates collagen matrix assembly and mineralization. Matrix Biol 28:44-52
43. Schönherr E, Sunderkötter C, Iozzo RV, Schaefer L 2005 Decorin, a novel player in the insulin-like growth factor system. J Biol Chem 280:15767-15772
44. Kresse H, Schönherr E 2001 Proteoglycans of the extracellular matrix and growth control. J Cell Physiol 189:266-274
45. Iozzo RV, Schaefer L 2010 Proteoglycans in health and disease: novel regulatory signaling mechanisms evoked by the small leucinerich proteoglycans. FEBS J 277:3864-3875
46. Iacob D, Cai J, Tsonis M, Babwah A, Chakraborty C, Bhattacharjee RN, Lala PK 2008 Decorin-mediated inhibition of proliferation and migration of the human trophoblast via different tyrosine kinase receptors. Endocrinology 149:6187-6197
47. Santra M, Reed CC, Iozzo RV 2002 Decorin binds to a narrow region of the epidermal growth factor (EGF) receptor, partially overlapping but distinct from the EGF-binding epitope. J Biol Chem 277:35671-35681
48. Gu N, Guo XR, Ni YH, Liu F, Fei L, Chen RH 2007 [Overexpression of resistin affect 3T3-L1 adipocyte lipid metabolism]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 24:251-255 (Chinese)
49. Agnetti G, Maraldi T, Fiorentini D, Giordano E, Prata C, Hakim G, Muscari C, Guarnieri C, Caldarera CM 2005 Activation of glucose transport during simulated ischemia in H9c2 cardiac myoblasts is mediated by protein kinase C isoforms. Life Sci 78:264-270
50. Turban S, Beardmore VA, Carr JM, Sakamoto K, Hajduch E, Arthur JS, Hundal HS 2005 Insulin-stimulated glucose uptake does not require p38 mitogen-activated protein kinase in adipose tissue or skeletal muscle. Diabetes 54:3161-3168
51. Khan AH, Pessin JE 2002 Insulin regulation of glucose uptake: a complex interplay of intracellular signalling pathways. Diabetologia 45:1475-1483
52. Tian R 2005 Another role for the celebrity: Akt and insulin resistance. Circ Res 96:139-140
53. Fisher JS 2006 Potential role of the AMP-activated protein kinase in regulation of insulin action. Cellscience 2:68-81
54. Porras A, Valladares A, Alvarez AM, Roncero C, Benito M 2002 Differential role of PPAR γ in the regulation of UCP-1 and adipogenesis by TNF-α in brown adipocytes. FEBS Lett 520:58-62
55. Ha do T, Trung TN, Phuong TT, Yim N, Chen QC, Bae K 2010 The selected flavonol glycoside derived from Sophorae Flos improves glucose uptake and inhibits adipocyte differentiation via activationAMPKin 3T3-L1 cells. Bioorg Med Chem Lett 20:6076-6081
56. Sánchez-Solana B, Nueda ML, Ruvira MD, Ruiz-Hidalgo MJ, Monsalve EM, Rivero S, García-Ramírez JJ, Díaz-Guerra MJ, Baladrón V, Laborda J 2011 The EGF-like proteins DLK1 and DLK2 function as inhibitory non-canonical ligands of NOTCH1 receptor that modulates each other's activities. Biochim Biophys Acta 1813: 1153-1164
57. Laborda J 1991 36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO. Nucleic Acids Res 19:3998